Compare STAA & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STAA | LMAT |
|---|---|---|
| Founded | 1982 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.9M | 2.2B |
| IPO Year | 1995 | 2006 |
| Metric | STAA | LMAT |
|---|---|---|
| Price | $29.72 | $95.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $22.81 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 965.6K | 238.5K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | 0.10 | ★ 0.68 |
| Revenue | $239,442,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $30.82 | $14.21 |
| Revenue Next Year | $8.41 | $8.88 |
| P/E Ratio | $292.50 | ★ $139.21 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $15.59 | $79.01 |
| 52 Week High | $35.87 | $118.01 |
| Indicator | STAA | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 34.63 |
| Support Level | $23.75 | $95.46 |
| Resistance Level | $35.87 | $99.95 |
| Average True Range (ATR) | 1.69 | 3.66 |
| MACD | -0.40 | -0.55 |
| Stochastic Oscillator | 33.12 | 14.57 |
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.